Search

Search Constraints

You searched for: Author/Creator Clements, Mark A

Search Results

2. Age at diagnosis predicts deterioration in glycaemic control among children and adolescents with type 1 diabetes. Issue 1 (7th October 2014)

4. Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial. Issue 3 (March 2023)